The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management
Open accessAbstract
Primary sclerosing cholangitis (PSC) is a chronic immune-mediated disease of the liver of unclear etiology, characterized by chronic inflammation and fibrosis of bile ducts. It primarily affects middle-aged men and is associated with 4-fold increased mortality as compared with an age- and sex-matched population. Progressive biliary and hepatic damage results in portal hypertension and hepatic failure in a significant majority of patients over a 10- to 15-year period from the initial diagnosis. In addition, PSC confers a markedly increased risk of hepatobiliary cancer, including cholangiocarcinoma and gallbladder cancer, as compared with the general population, and cancer is the leading cause of mortality in patients with PSC. It is associated with inflammatory bowel disease in 70% of patients and increases the risk of colorectal cancer almost 10-fold. Despite significant research efforts in this field, the pathogenic mechanisms of PSC are still incompletely understood, although growing evidence supports the role of genetic and immunologic factors. There are no proven medical therapies that alter the natural course of the disease. Thus, liver transplantation is the only available treatment for patients with advanced PSC, with excellent outcomes in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a small percentage of patients, CSPH in PSC (in analogy to PBC) may occur early in the disease course, i.e. even in people with PSC with F2 or F3 fibrosis in the absence of full-blown histologic cirrhosis.250”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [250]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R. W., Fevery, J., Kalloo, A. N., Nagorney, D. M., Boberg, K. M., Shneider, B. L., & Gores, G. J. (2009) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,230
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
Ghazale, A., Chari, S. T., Zhang, L., Smyrk, T. C., Takahashi, N., Levy, M. J., Topazian, M. D., Clain, J. E., Pearson, R. K., Petersen, B. T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.009 · Cited by 890
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg–Gertzén, H., Wallerstedt, S. M., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 816
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Loftus, E. V., Harewood, G. C., Loftus, C. G., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Jewell, D. A., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.046615 · Cited by 777
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Wiesner, R. H., Grambsch, P. M., Dickson, E. R., Ludwig, J., MacCarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & LaRusso, N. F. (1989) · Hepatology · doi:10.1002/hep.1840100406 · Cited by 641
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Boonstra, K., Beuers, U., & Ponsioen, C. Y. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.025 · Cited by 632
Soetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S., & Blackstone, M. O. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.125367 · Cited by 623
Ursodiol for Primary Sclerosing Cholangitis
Lindor, K. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361003 · Cited by 598
Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., Botha, J. F., Mezrich, J. D., Chapman, W. C., Schwartz, J. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.008 · Cited by 597
Pardi, D. S., Loftus, E. V., Kremers, W. K., Keach, J. C., & Lindor, K. D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50156 · Cited by 557
Clinicopathologic features of the syndrome of primary sclerosing cholangitis
Wiesner, R. H., & LaRusso, N. F. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90131-6 · Cited by 556
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K. W., Angulo, P., Pasha, T. M., Egan, K. M., Petz, J., & Lindor, K. D. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 554
Farraye, F. A., Odze, R. D., Eaden, J., & Itzkowitz, S. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.037 · Cited by 530
Boberg, K. M. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850166284 · Cited by 515
Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer
Hagness, M., Foss, A. E., Line, P., Scholz, T., Jørgensen, P. F., Fosby, B., Boberg, K. M., Mathisen, Ø., Gladhaug, I. P., Egge, T. S., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182823957 · Cited by 472
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R. G. E., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468
Tung, B. Y., Emond, M. J., Haggitt, R. C., Bronner, M. P., Kimmey, M. B., Kowdley, K. V., & Brentnall, T. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00008 · Cited by 464
Bambha, K. M., Kim, W. R., Talwalkar, J. A., Torgerson, H., Benson, J. T., Therneau, T. M., Loftus, E. V., Yawn, B. P., Dickson, E. R., & Melton, L. J. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.011 · Cited by 448
Self-citationAssessment of biliary fibrosis by transient elastography in patients with PBC and PSC
Corpechot, C., El Naggar, A., Poujol-Robert, A., Ziol, M., Wendum, D., Chazouillères, O., de Lédinghen, V., Dhumeaux, D., Marcellin, P., Beaugrand, M., et al. (2006) · Hepatology · doi:10.1002/hep.21151 · Cited by 441
A Revised Natural History Model for Primary Sclerosing Cholangitis
Kim, W. R., Therneau, T. M., Wiesner, R. H., Poterucha, J. J., Benson, J. T., Malinchoc, M., LaRusso, N. F., Lindor, K. D., & Dickson, E. R. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64614-4 · Cited by 438
A revised natural history model for primary sclerosing cholangitis.
Kim, W., Therneau, T., Wiesner, R., Poterucha, J. J., Benson, J., Malinchoc, M., LaRusso, N., Lindor, K., & Dickson, E. (1997) · Mayo Clinic proceedings · doi:10.4065/75.7.688 · Cited by 417
Tischendorf, J. J. W., Hecker, H., Krüger, M., Manns, M. P., & Meier, P. N. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00872.x · Cited by 413
High lifetime risk of cancer in primary sclerosing cholangitis
Claessen, M. M., Vleggaar, F. P., Tytgat, K. M. A. J., Siersema, P. D., & van Buuren, H. R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.013 · Cited by 408
Charatcharoenwitthaya, P., Enders, F. B., Halling, K. C., & Lindor, K. D. (2008) · Hepatology · doi:10.1002/hep.22441 · Cited by 393
Recurrence of Primary Sclerosing Cholangitis Following Liver Transplantation
Graziadei, I. W., Wiesner, R. H., Batts, K. P., Marotta, P. J., LaRusso, N. F., Porayko, M. K., Hay, E. J., Gores, G. J., Charlton, M., Ludwig, J., et al. (1999) · Hepatology · doi:10.1002/hep.510290427 · Cited by 370
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
Karlsen, T. H., Franke, A., Melum, E., Kaser, A., Hov, J. R., Balschun, T. C., Lie, B. A., Bergquist, A. M., Schramm, C., Weismüller, T. J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.11.046 · Cited by 365
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis
Graziadei, I. W., Wiesner, R. H., Marotta, P. J., Porayko, M. K., Hay, J. E., Charlton, M., Poterucha, J. J., Rosen, C. B. B., Gores, G. J., LaRusso, N. F., et al. (1999) · Hepatology · doi:10.1002/hep.510300501 · Cited by 357
Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis
Mendes, F. D., Jorgensen, R., Keach, J. C., Katzmann, J. A., Smyrk, T. C., Donlinger, J. J., Chari, S. T., & Lindor, K. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00772.x · Cited by 335
[Primary sclerosing cholangitis].
Molina Jurado, M., Ferrer, J., & Gómez, N. (1984) · PubMed · Cited by 335
Primary sclerosing cholangitis: findings on cholangiography and pancreatography.
MacCarty, R. L., LaRusso, N. F., Wiesner, R. H., & Ludwig, J. (1983) · Radiology · doi:10.1148/radiology.149.1.6412283 · Cited by 331
Ludwig, J., Barham, S. S., LaRusso, N. F., Elveback, L. R., Wiesner, R. H., & McCall, J. (1981) · Hepatology · doi:10.1002/hep.1840010612 · Cited by 326
Advanced Cytologic Techniques for the Detection of Malignant Pancreatobiliary Strictures
Luna, L. E. M., Kipp, B. R., Halling, K. C., Sebo, T. J., Kremers, W. K., Roberts, L. R., Fritcher, E. G. B., Levy, M. J., & Gores, G. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.021 · Cited by 311
The natural history of small-duct primary sclerosing cholangitis
Björnsson, E., Olsson, R., Bergquist, A., Lindgren, S., Braden, B., Chapman, R. W., Boberg, K. M., & Angulo, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.042 · Cited by 305
Alabraba, E., Nightingale, P., Gunson, B., Hubscher, S., Olliff, S., Mirza, D., & Neuberger, J. (2009) · Liver Transplantation · doi:10.1002/lt.21679 · Cited by 298
Cancer surveillance in patients with primary sclerosing cholangitis
Razumilava, N., Gores, G. J., & Lindor, K. D. (2011) · Hepatology · doi:10.1002/hep.24570 · Cited by 290
Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis
Molodecky, N. A., Kareemi, H., Parab, R., Barkema, H. W., Quan, H., Myers, R. P., & Kaplan, G. G. (2011) · Hepatology · doi:10.1002/hep.24247 · Cited by 274
Kaplan, G. G., Laupland, K. B., Butzner, D., Urbanski, S. J., & Lee, S. S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01103.x · Cited by 273
Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A., Harrison, E. M., McCashland, T. M., Befeler, A. S., Harnois, D. M., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.156 · Cited by 270
Ponsioen, C. Y., Vrouenraets, S. M. E., Prawirodirdjo, W., Rajaram, R., Rauws, E. A., Mulder, C. J. J., Reitsma, J. B., Heisterkamp, S. H., & Tytgat, G. N. J. (2002) · Gut · doi:10.1136/gut.51.4.562 · Cited by 267
Primary sclerosing cholangitis: refinement and validation of survival models.
Dickson, E., Murtaugh, P., Wiesner, R., Grambsch, P. M., Fleming, T. R., Ludwig, J., LaRusso, N., Malinchoc, M., Chapman, R., Kaplan, M., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91449-e · Cited by 265
Fleshner, P. R., Vasiliauskas, E. A., Kam, L. Y., Fleshner, N. E., Gaiennie, J., Abreu-Martin, M. T., & Targan, S. R. (2001) · Gut · doi:10.1136/gut.49.5.671 · Cited by 259
Grant, A. J., Lalor, P. F., Salmi, M., Jalkanen, S., & Adams, D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07374-9 · Cited by 255
Primary sclerosing cholangitis: Summary of a workshop
LaRusso, N. F., Shneider, B. L., Black, D. D., Gores, G. J., James, S. P., Doo, E. C., & Hoofnagle, J. H. (2006) · Hepatology · doi:10.1002/hep.21337 · Cited by 252
Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis
Jaffe, D. L. (2007) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70051-5 · Cited by 251
The Spectrum of Liver Diseases Related toABCB4Gene Mutations: Pathophysiology and Clinical Aspects
Spraul, A., Gonzales, E. M., Baussan, C., & Jacquemin, E. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1253223 · Cited by 245
Björnsson, E. S., Chari, S. T., Smyrk, T. C., & Lindor, K. D. (2007) · Hepatology · doi:10.1002/hep.21685 · Cited by 242
Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome
Floreani, A., Rizzotto, E. R., Ferrara, F., Carderi, I., Caroli, D., Blasone, L., & Baldo, V. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41841.x · Cited by 230
Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis
Baluyut, A. R., Sherman, S., Lehman, G. A., Hoen, H. M., & Chalasani, N. (2001) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(01)70403-8 · Cited by 219
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases
Mulder, A. H. L. (1993) · Hepatology · doi:10.1016/0270-9139(93)90052-o · Cited by 212
Bone mineral density before and after OLT: Long-term follow-up and predictive factors
Guichelaar, M. M. J., Kendall, R. K., Malinchoc, M., & Hay, J. E. (2006) · Liver Transplantation · doi:10.1002/lt.20874 · Cited by 203
Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis
Kaya, M., Petersen, B. T., Angulo, P., Baron, T. H., Andrews, J. C., Gostout, C. J., & Lindor, K. D. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03690.x · Cited by 196
Gallbladder disease in patients with primary sclerosing cholangitis
Said, K., Glaumann, H., & Bergquist, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.019 · Cited by 193
Kaya, M., Angulo, P., & Lindor, K. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80004-5 · Cited by 193
Lewis, J. T., Talwalkar, J. A., Rosen, C. B. B., Smyrk, T. C., & Abraham, S. C. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213435.99492.8a · Cited by 186
Self-citationBalloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis
Kaya, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02253-5 · Cited by 186
Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis
Joo, M., de Abreu-e-Lima, P. C., Farraye, F. A., Smith, T. M., Swaroop, P. P., Gardner, L., Lauwers, G. Y., & Odze, R. D. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318196d018 · Cited by 184
Verdonk, R. C., Dijkstra, G. D. H., Haagsma, E. B., Shostrom, V., van den Berg, A. P., Kleibeuker, J. H., Langnas, A. N., & Sudan, D. L. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01333.x · Cited by 183
Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
Fosby, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i1.1 · Cited by 175
Is There A Role for Liver Biopsy in Primary Sclerosing Cholangitis?
Burak, K. W., Angulo, P., & Lindor, K. D. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07401.x · Cited by 165
Serum autoantibodies in patients with primary sclerosing cholangitis
Angulo, P., Peter, J. B., Gershwin, M. E., DeSotel, C. K., Shoenfeld, Y., Ahmed, A. E. E., & Lindor, K. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80061-6 · Cited by 165
Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis
Baluyut, A. R., Sherman, S., Lehman, G. A., Hoen, H. M., & Chalasani, N. (2001) · Gastrointestinal Endoscopy · doi:10.1067/mge.2001.112739 · Cited by 164
Angulo, P., Pearce, D. H., Johnson, C. D., Henry, J. J., LaRusso, N. F., Petersen, B. T., & Lindor, K. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80002-1 · Cited by 159
Halilbasic, E., Fiorotto, R., Fickert, P., Marschall, H., Moustafa, T., Spirlı̀, C., Fuchsbichler, A., Gumhold, J., Silbert, D., Zatloukal, K., et al. (2009) · Hepatology · doi:10.1002/hep.22891 · Cited by 157
Rudolph, G., Gotthardt, D., Klöters-Plachky, P., Kulaksiz, H., Rost, D., & Stiehl, A. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.023 · Cited by 156
Etiopathogenesis of Primary Sclerosing Cholangitis
O'Mahony, C. A., & Vierling, J. M. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933559 · Cited by 156
Terjung, B., Söhne, J., Lechtenberg, B., Gottwein, J. M., Muennich, M., Herzog, V., Mähler, M., Sauerbruch, T., & Spengler, U. (2009) · Gut · doi:10.1136/gut.2008.157818 · Cited by 153
Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis
Bangarulingam, S. Y., Gossard, A. A., Petersen, B. T., Ott, B. J., & Lindor, K. D. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.161 · Cited by 152
Berstad, A. E., Aabakken, L., Smith, H., Aasen, S., Boberg, K. M., & Schrumpf, E. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.10.007 · Cited by 149
Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis
Wiesner, R. H., LaRusso, N. F., Dozois, R. R., & Beaver, S. J. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90926-1 · Cited by 148
Increased prevalence of primary sclerosing cholangitis among first-degree relatives
Bergquist, A. M., Lindberg, G., Saarinen, S., & Broomé, U. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.011 · Cited by 146
Kingham, J. G. C., Kochar, N., & Gravenor, M. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.052 · Cited by 145
Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease
Porayko, M. K., Wiesner, R. H., LaRusso, N. F., Ludwig, J., MacCarty, R. L., Steiner, B. L., Twomey, C. K., & Zinsmeister, A. R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91096-o · Cited by 139
Pathogenesis of primary sclerosing cholangitis
Pollheimer, M. J., Halilbasic, E., Fickert, P., & Trauner, M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.10.009 · Cited by 135
Bone disease in patients with primary sclerosing cholangitis
Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K. D., Bjornsson, E., & Koch, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.014 · Cited by 133
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis
Triantos, C. K., Koukias, N. M., Nikolopoulou, V. N., & Burroughs, A. K. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04822.x · Cited by 132
Primary sclerosing cholangitis is associated with nonsmoking: A case- control study
Loftus, E. V., Sandborn, W., Tremaine, W., Mahoney, D., Zinsmeister, A., Offord, K., & Melton, L. J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613055 · Cited by 129
Kornfeld, D., Ekbom, A., & Ihre, T. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011222 · Cited by 128
Is there a role for liver biopsy in primary sclerosing cholangitis?
Burak, K. W. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00105-9 · Cited by 125
Primary Sclerosing Cholangitis
Talwalkar, J. A., & Lindor, K. D. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00009 · Cited by 123
Self-citationOkolicsànyi, L., Fabris, L., Viaggi, S., Carulli, N., Podda, M., & Ricci, G. (1996) · PubMed · Cited by 120
Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis
Talwalkar, J. A., Angulo, P., Johnson, D. C., Petersen, B. T., & Lindor, K. D. (2004) · Hepatology · doi:10.1002/hep.20287 · Cited by 119
Self-citationMitchell, S. A. (2002) · Gut · doi:10.1136/gut.51.4.567 · Cited by 118
Surgical pathology of the syndrome of primary sclerosing cholangitis.
Ludwig, J. (1989) · PubMed · Cited by 113
Haagsma, E. B., Berg, A. P. V. D., Kleibeuker, J. H., Slooff, M. J. H., & Dijkstra, G. D. H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01613.x · Cited by 113
Gallbladder disease in patients with primary sclerosing cholangitis
Brandt, D., MacCarty, R. L., Charboneau, J. W., LaRusso, N. F., Wiesner, R., & Ludwig, J. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.150.3.571 · Cited by 108
Risk of primary sclerosing cholangitis is associated with nonsmoking behavior
van Erpecum, K. J., Smits, S. R. J. G., van de Meeberg, P., Linn, F. H. H., Wolfhagen, F. H. J., Henegouwen, G. P. V. B., & Algra, A. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613056 · Cited by 105
Johnson, G. K., Geenen, J. E., Venu, R. P., Schmalz, M. J., & Hogan, W. J. (1991) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(91)70618-4 · Cited by 101
Mitchell, S. A., Grove, J., Spurkland, A., Boberg, K. M., Fleming, K. A., Day, C. P., Schrumpf, E., Chapman, R. W., & the European Study Group of Primary Sclerosing Cholangitis (2001) · Gut · doi:10.1136/gut.49.2.288 · Cited by 100
Serum Lipid and Fat-Soluble Vitamin Levels in Primary Sclerosing Cholangitis
Jorgensen, R. A., Lindor, K. D., Sartin, J. S., LaRusso, N. F., & Wiesner, R. H. (1995) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199504000-00011 · Cited by 99
Eaton, J. E., Thackeray, E. W., & Lindor, K. D. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.361 · Cited by 97
Sokol, H., Cosnes, J., Chazouillères, O., Beaugerie, L., Tiret, E., Poupon, R. Y., & Seksik, P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3497 · Cited by 96
Satsangi, J., Chapman, R. W., Haldar, N. A., Donaldson, P. T., Mitchell, S., Simmons, J. D., Norris, S., Marshall, S. E., Bell, J. I., Jewell, D. P., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.25527 · Cited by 95
Textor, H. J., Flacke, S., Pauleit, D. O., Keller, E., Neubrand, M., Terjung, B., Gieseke, J., Scheurlen, C., Sauerbruch, T., & Schild, H. H. (2002) · Endoscopy · doi:10.1055/s-2002-35830 · Cited by 95
Singh, S., Khanna, S., Pardi, D. S., Loftus, E. V., & Talwalkar, J. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318286fa61 · Cited by 94
Self-citationA unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease
Halliday, J., Djordjević, J., Lust, M., Culver, E. L., Braden, B., Travis, S. P. L., & Chapman, R. W. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.07.015 · Cited by 91
Bansi, D. S., Fleming, K. A., & Chapman, R. W. (1996) · Gut · doi:10.1136/gut.38.3.384 · Cited by 85
Beuers, U. H., & Rust, C. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-916322 · Cited by 84
Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease
O’Toole, A., Alakkari, A., Keegan, D., Doherty, G. A., Mulcahy, H. E., & O’Donoghue, D. P. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.11.010 · Cited by 82
Abraham, S. C., Kamath, P. S., Eghtesad, B., Demetris, A. J., & Krasinskas, A. M. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213286.65907.ea · Cited by 72
Pruritus in Chronic Cholestatic Liver Disease
Bunchorntavakul, C., & Reddy, K. R. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.010 · Cited by 71
Resection of Hepatic Duct Bifurcation and Transhepatic Stenting for Sclerosing Cholangitis
Cameron, J. L., Pitt, H. A., Zinner, M. J., Herlong, H. F., Kaufman, S. L., Boitnott, J. K., & Coleman, J. (1988) · Annals of Surgery · doi:10.1097/00000658-198805000-00016 · Cited by 68
Xuesong, Y., Cullen, S. N., Li, J., Chapman, R. W., & Jewell, D. P. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.009 · Cited by 67
Thackeray, E. W., Charatcharoenwitthaya, P., Elfaki, D., Sinakos, E., & Lindor, K. D. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.09.020 · Cited by 61
Primary sclerosing cholangitis: overview and update
Mendes, F. D., & Lindor, K. D. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.155 · Cited by 59
Egawa, H., Taira, K., Teramukai, S., Haga, H., Ueda, Y., Yonezawa, A., Masuda, S., Tsuji, H., Ashihara, E., Takada, Y., et al. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0773-9 · Cited by 58
Culver, E. L., & Chapman, R. W. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04658.x · Cited by 57
Lepistö, A., Kärkkäinen, P. A., & Järvinen, H. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20384 · Cited by 56
Surgical Biliary Drainage in Primary Sclerosing Cholangitis
Myburgh, J. A. (1994) · Archives of Surgery · doi:10.1001/archsurg.1994.01420340071012 · Cited by 35
Small-duct primary sclerosing cholangitis
Bjornsson, E. S. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0006-6 · Cited by 34
Liver Transplantation for Non-Resectable Liver Metastases from Colorectal Cancer
Hagness, M., Foss, A., Line, P., Scholz, T., Jørgensen, P. F., Fosby, B., Boberg, K. M., Mathisen, Ø., Gladhaug, I. P., Hausken, J., et al. (2012) · Transplantation · doi:10.1097/00007890-201211271-00091 · Cited by 17
Singh, S., Khanna, S., Pardi, D. S., Loftus, E. V., & Talwalkar, J. A. (2012) · Inflammatory Bowel Diseases · doi:10.1097/00054725-201212001-00071 · Cited by 2
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Karlsen, 2009, The Nordic liver transplant registry, Annu Rep, 2012, 2009
Cited by
Sorted by citations
Cancers Complicating Inflammatory Bowel Disease
Beaugerie, L., & Itzkowitz, S. H. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403718 · Cited by 692
Axelrad, J. E., Lichtiger, S., & Yajnik, V. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i20.4794 · Cited by 431
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Chronic ulcerative colitis and colorectal cancer
Rogler, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.032 · Cited by 421
Guy, J. E., & Peters, M. G. (2013) · Europe PMC (PubMed Central) · Cited by 244
Metadata
- Authors
- Singh, S., & Talwalkar, J. A.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Talwalkar, Jayant A.
- ORCID
- Singh, Siddharth
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 11
- Issue
- 8
- Pages
- 898-907
- ISSN
- 1542-3565 (ISSN-L)
- PMC
- PMC3692584
- OpenAlex
- W2076789082
- Cited by
- 119
- References
- 114
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 10 · 2017: 11 · 2016: 9 · 2015: 13 · 2014: 13 · 2013: 6
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Gastroenterology and Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056924)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- primary sclerosing cholangitis, bile duct inflammation, liver fibrosis, portal hypertension, hepatobiliary cancer, cholangiocarcinoma, gallbladder cancer, inflammatory bowel disease, colorectal cancer risk, liver transplantation, prognosis, pathogenesis, immune-mediated liver disease
- MeSH terms
- Bile Ducts, Gallbladder Neoplasms, Humans, Hypertension, Portal, Liver Neoplasms, Prognosis, Cholangitis, Sclerosing, Liver Transplantation, Liver Failure, Cholangiocarcinoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review